SEC Form 4 · accession 0001140361-18-042452
CHEMBIO DIAGNOSTICS, INC. · CEMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Passas
Officer — See Remarks
Period of report
Nov 5, 2018
Accepted (ET)
Nov 6, 2018 · 9:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001092662
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 5, 2018 | P | 15,000 | $6.75 | A | 15,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased in Chembio Diagnostics, Inc.'s registered public offering of its Common Stock, which was consummated on November 5, 2018.
Remarks
Senior Vice President, Chief Commercial Officer